Spinal cord injuries are life-altering, often leaving individuals with severe mobility impairments. While rehabilitation robotics—devices that guide ...

Scientists at .Neurorestore (EPFL/CHUV/UNIL) have developed an approach that combines rehabilitation robotics with spinal ...

The global motion stimulation therapy market is set for significant growth, with market projections estimating its value at USD 1.4 billion in 2024. Fueled by rapid technological integration in ...

The Japanese wound care market is set to witness significant growth in the coming years, expanding at a compound annual growth rate (CAGR) of 7.59% from 2025 to 2033. According to market research, the ...

The global extracorporeal membrane oxygenation machine market is on a growth trajectory, with revenue anticipated to reach ...

Future technology will also address other Parkinson’s symptoms, like depression and sleep dysfunction. Credit: Neuroscience News The FDA approval covers two treatment algorithms that run on a device ...

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

approved a new deep brain stimulator that could benefit patients with the motor condition. On Feb 24, the FDA approved Medtronic’s BrainSense Adaptive deep brain stimulation, a device that ...

Medtronic's BrainSense aDBS personalizes Parkinson's therapy in real-time, minimizing manual adjustments for better symptom control. BrainSense Electrode Identifier speeds up initial DBS ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach ...

By using the electrode identifier, clinicians can conduct an accurate initial programming more quickly compared with traditional electrode selection, Medtronic said. The BrainSense adaptive DBS ...